Palantir: A Great Company Isn't a Great Investment at 130x Cash Flow

TL;DR Palantir is a genuinely great company — 84% gross margins and an essentially debt-free balance sheet. But at more than 130x recent free cash flow, that price is hard to justify even if you assume 20% revenue growth and 50%-plus net margins for a decade. My base-case fair value is $74; the stock trades near $136. The business isn't the problem. The price is.

What Palantir actually sells

Let me start with the plain version: Palantir builds software that takes enormous, messy piles of data and turns them into clear answers organizations can act on. Governments use it for defense and intelligence; big companies use it to run operations more intelligently. If that sounds generic, it is — it's roughly how the company has always described itself. The real question was never whether Palantir is impressive. It's whether the price you'd pay today makes any sense.

Why the balance sheet impresses me first

The first thing I look at is the balance sheet, and here it's excellent. Market cap sits around $350 billion, while enterprise value is about $342 billion. When enterprise value is lower than market cap, it means the company is sitting on a lot of net cash. There is some debt, but it can be paid off entirely with cash on hand and still leave money left over. That's not merely good — it's a genuinely strong financial position.

Profitability is there too. Net margin averaged around 16% over the last five years but hit 44% last year. What I like most is the relationship between free cash flow and net income: roughly $1 billion in cumulative five-year free cash flow against about $480 million in net income. Free cash flow above net income is a good sign, because net income can be massaged by accounting rules, practices, or outright fraud, while actual cash is much harder to fake.

On top of that, return on capital is now above 15% — a metric that used to be a weak spot and no longer is. And the gross margin is 84%. Every new contract they sign drops 84% of its revenue to profit before overhead and taxes. With margins like that, they don't need enormous growth to push profit and cash flow higher.

Strength and weakness in eight numbers

Run Palantir through the eight-point checklist I use and it comes out exactly split. Low debt, rising revenue, rising net income, rising cash flow — those pass easily.

The other half is where it gets uncomfortable. First, dilution: shares outstanding are up 26%. They're issuing a lot of stock to employees — "everyone wants our stock, so let's hand it out" — and that erodes existing shareholders. I don't like it. Second, valuation: the five-year P/E and five-year price-to-free-cash-flow are extreme, and even on recent numbers it's north of 130x free cash flow. That's a lot. But no single metric makes a stock cheap or expensive on its own. If this company doubled its profit every year for 30 years, 130x would be a steal. When you buy a stock you're paying for the future, not the past — the catch is that the future has to be enormous to justify this price.

The valuation I actually ran

Here's the part that matters, because I trust numbers over stories. On a 10-year basis I plugged in deliberately generous assumptions.

For revenue growth I used 12%, 20%, and 30%. You might insist Palantir will grow faster than 20%, and maybe it will — but a company worth hundreds of billions compounding revenue at 20% a year is genuinely hard to pull off. For net and free-cash-flow margins I went higher, to 35%, 45%, and 55%. For the P/E I'd assign a decade out I used 20, 25, and 30 — generous, given the market's long-run average is 15–16. Personally I'd put 22 rather than 25 in the middle, but I left room for the bulls. Desired return: 9%, with no margin of safety.

The output: a low fair value of $26, a high of $222, and a base case of $74. With the stock near $136, my base case implies roughly a 2% forward return. Great company, wrong price.

So, is it a buy right now

My position is clear. On business quality alone, Palantir is hard to fault — rising returns on capital, a strong balance sheet, rapid growth, and what looks like leadership in its category. Absent something like fraud, you can't really call this a bad company.

But remember the fifth tenet of principle-driven investing: a great story becomes a bad investment if you pay the wrong price. I'll go further — even great numbers become a bad investment at the wrong price. The 4.5x revenue growth analysts model (from roughly $7.5 billion to $33 billion) combined with 84% gross margins does create real profit leverage. Even so, today's price already borrows most of that optimism.

I ran CrowdStrike and Snowflake through the same lens, and all three share the same trait: excellent businesses that stumble on price. In this market, investing is as much about what you pay as what you buy.